News Releases
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLTâ„¢ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
Allflex Livestock Intelligence is the global leader in the design, development, manufacture and delivery of animal identification and monitoring devices.
State-of-the-art products and services that help pets live longer, healthier lives.
Investing in science-backed solutions that make a real and meaningful impact in protecting and preserving the future of our planet.
MSD Animal Health firmly supports the responsible use of antibiotics to improve and maintain the health of animals.
Our commitment to animal health and welfare is central to everything we do.
We responsibly test our investigative Animal Health pharmaceuticals and vaccines vigorously for safety, quality and efficacy before submitting them for approval, which can be obtained only after thorough review by independent regulatory authorities.
We partner with like-minded companies to develop products and solutions that directly address unmet customer needs and further advance animal health.
Industry-leading biopharmaceutical and technology solutions that ensure the health, welfare and sustainability of aquatic species.Â
Pioneering medicines, vaccines, technology, and insights-driven solutions that aim to improve the health and well-being of ruminants, enable a sustainable meat and dairy supply, and protect public health.
Innovative products and solutions that make a difference, improving poultry health, welfare, and productivity.
Differentiated health solutions focused on improving swine health and farm sustainability.